3 insider filings
Sumita Ray, insider filing for CUE
Show all 3
- 4Insider filing for CUE
- 4Insider filing for CUE
- 4Insider filing for CUE
Sumita Ray, reporting
CUE
Cue Biopharma, Inc. SEC filings
Every EDGAR filing for Cue Biopharma, Inc. (CUE), newest first, with AI summaries and stories.
- Ticker
- CUE
- CIK
- 1645460
- Sector
- Biotech and pharma
- Latest filing
- 4d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
4Cue Biopharma, Inc.CUELIVE 144Cue Biopharma, Inc.CUELIVE 2 Form 144 notices
Shao-Lee Lin, planned sale of CUE shares
Show all 2
- 144Planned insider sale of CUE shares
- 144Planned insider sale of CUE shares
Shao-Lee Lin, reporting
SCHEDULE 13G/ACue Biopharma, Inc.CUELIVE Cue Biopharma, Inc. (CUE) reports major shareholder changes.
- Mark E. Strome owns 644,916 shares (8.50%)
- Strome Group, Inc. holds 643,242 shares (8.48%)
- Mezzanine II holds 593,242 shares (7.82%)
Mark E Strome, filed by
8-KCue Biopharma, Inc.CUELIVE 4/ACue Biopharma, Inc.CUELIVE 2 insider filings
Pasha Sarraf, insider filing for CUE (amended)
Show all 2
- 4/AInsider filing for CUE (amended)
- 4/AInsider filing for CUE (amended)
Pasha Sarraf, reporting
SCHEDULE 13DCue Biopharma, Inc.CUELIVE Ownership stake disclosure by Shao-Lee Lin
Shao-Lee Lin, filed by
EFFECTCue Biopharma, Inc.CUELIVE 4Cue Biopharma, Inc.CUELIVE 2 insider filings
Sumita Ray, insider filing for CUE
Show all 2
- 4Insider filing for CUE
- 4Insider filing for CUE
Sumita Ray, reporting
4Cue Biopharma, Inc.CUELIVE Shao-Lee Lin, insider filing for CUE
Shao-Lee Lin, reporting
144Cue Biopharma, Inc.CUELIVE Shao-Lee Lin, planned sale of CUE shares
Shao-Lee Lin, reporting
8-KCue Biopharma, Inc.CUELIVE 10-QCue Biopharma, Inc.CUELIVE SCHEDULE 13GCue Biopharma, Inc.CUELIVE Ownership stake disclosure by DRIEHAUS CAPITAL MANAGEMENT LLC
DRIEHAUS CAPITAL MANAGEMENT LLC, filed by
144Cue Biopharma, Inc.CUELIVE Sumita Ray, planned sale of CUE shares
Sumita Ray, reporting
S-3Cue Biopharma, Inc.CUELIVE 8-KCue Biopharma, Inc.CUELIVE 4Cue Biopharma, Inc.CUELIVE 2 insider filings
James M Ahlers, insider filing for CUE
Show all 2
- 4Insider filing for CUE
- 3New insider at CUE
James M Ahlers, reporting
4/ACue Biopharma, Inc.CUELIVE Shao-Lee Lin, insider filing for CUE (amended)
Shao-Lee Lin, reporting
DCue Biopharma, Inc.CUELIVE 4Cue Biopharma, Inc.CUELIVE 2 insider filings
Dominique Christian Borie, insider filing for CUE
Show all 2
- 4Insider filing for CUE
- 3New insider at CUE
Dominique Christian Borie, reporting
4Cue Biopharma, Inc.CUELIVE 7 insider filings
Pamela Garzone, insider filing for CUE
Show all 7
- 4Insider filing for CUE
- 4Insider filing for CUE
- 4Insider filing for CUE
- 4Insider filing for CUE
- 4Insider filing for CUE
- 4Insider filing for CUE
- 4Insider filing for CUE
Pamela Garzone, reporting
8-KCue Biopharma, Inc.CUELIVE EFFECTCue Biopharma, Inc.CUELIVE S-3Cue Biopharma, Inc.CUELIVE EFFECTCue Biopharma, Inc.CUELIVE 3Cue Biopharma, Inc.CUELIVE 2 insider filings
Michael Vincent Meluzio, new insider at CUE
Show all 2
- 3New insider at CUE
- 3New insider at CUE
Michael Vincent Meluzio, reporting
4Cue Biopharma, Inc.CUELIVE 2 insider filings
Daniel A. Camardo, insider filing for CUE
Show all 2
- 4Insider filing for CUE
- 3New insider at CUE
Daniel A. Camardo, reporting
4Cue Biopharma, Inc.CUELIVE Shao-Lee Lin, insider filing for CUE
Shao-Lee Lin, reporting
8-KCue Biopharma, Inc.CUELIVE S-3Cue Biopharma, Inc.CUELIVE S-8Cue Biopharma, Inc.CUELIVE 4Cue Biopharma, Inc.CUELIVE 2 insider filings
Viola Mong Meehan, insider filing for CUE
Show all 2
- 4Insider filing for CUE
- 3New insider at CUE
Viola Mong Meehan, reporting
8-KCue Biopharma, Inc.CUELIVE DEF 14ACue Biopharma, Inc.CUELIVE